6 results
Antiplatelet Conversion - Switching Between P2Y12 Inhibitors
Oral P2Y12 inhibitors vary in potency and pharmacokinetic and dynamic
Between P2Y12 Inhibitors ... Oral P2Y12 inhibitors ... inhibitors during ... between P2Y12 inhibitors ... ticagrelor #prasugrel #pharmacology
Antiplatelet Conversion - P2Y12 Inhibitor Switching
 • Clopidogrel (Plavix)
 • Prasugrel (Effient)
 • Ticagrelor (Brilinta)
Clopidogrel and
Conversion - P2Y12 Inhibitor ... SwitchingClopidogrel ... • Irreversible inhibitor ... • Reversible inhibitor ... #Switching #pharmacology
Antiplatelet Conversion - Switching Between Oral P2Y12 Inhibitors
A, Switching between oral agents in the acute/early phase.
Between Oral P2Y12 Inhibitors ... administration of a loading ... .117.031164 #P2Y12 #Inhibitor ... #Clopidogrel #plavix ... ticagrelor #prasugrel #pharmacology
Summary of characteristics of Platelet Aggregation Inhibitors

#AntiPlatelet #Inhibitors #Pharmacology #Table #Overview #Interactions #Pharmacology #Cardiology
Platelet Aggregation Inhibitors ... #AntiPlatelet #Inhibitors ... #Pharmacology # ... Table #Overview ... #Cardiology
Clinically Significant Cardiovascular Drug-Drug Interactions With OTC Supplements and Herbal Products
Angiotensin-Converting Enzyme Inhibitors (ACEIs)
 • Night-blooming
Angiotensin-Converting Enzyme Inhibitors ... Increases activity of clopidogrel ... Monoamine Oxidase Inhibitors ... supplementals #herbal #pharmacology ... #DDI #table #cardiology
Cangrelor - Pharmacology
Cangrelor (Kengreal) is a parenteral analogue of adenosine triphosphate
Cangrelor binds reversibly to the platelet
Cangrelor - Pharmacology ... an oral P2Y12 inhibitor ... artery bypass grafting ... prasugrel and clopidogrel ... the effects of clopidogrel